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Dendritic spines represent the major postsynaptic input of excitatory synapses. Loss of spines and
changes in their morphology correlate with cognitive impairment in Alzheimer's disease (AD) and are
thought to occur early during pathology. Therapeutic intervention at a preclinical stage of AD to modify
spine changes might thus be warranted. To follow the development and to potentially interfere with
spine changes over time, we established a long term ex vivo model from organotypic cultures of the
hippocampus from APP transgenic and control mice. The cultures exhibit spine loss in principal hip-
pocampal neurons, which closely resembles the changes occurring in vivo, and spine morphology pro-
gressively changes from mushroom-shaped to stubby. We demonstrate that spine changes are
completely reversed within few days after blocking amyloid-b (Ab) production with the gamma-
secretase inhibitor DAPT. We show that the microtubule disrupting drug nocodazole leads to spine
loss similar to Ab expressing cultures and suppresses DAPT-mediated spine recovery in slices from APP
transgenic mice. Finally, we report that epothilone D (EpoD) at a subnanomolar concentration, which
slightly stabilizes microtubules in model neurons, completely reverses Ab-induced spine loss and in-
creases thin spine density. Taken together the data indicate that Ab causes spine changes by microtubule
destabilization and that spine recovery requires microtubule polymerization. Moreover, our results
suggest that a low, subtoxic concentration of EpoD is sufﬁcient to reduce spine loss during the preclinical
stage of AD.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Alzheimer's disease (AD) is characterized by massive alterations
of the synaptic network as evidenced by loss of postsynaptic spines
as well as changes in spine morphology (Baloyannis et al., 2007).
Spine loss correlates with cognitive impairment (Scheff et al.,
2007), indicating that spine alterations act as a major factorgy, University of Osnabrück,
e (R. Brandt).
ich, Switzerland.
Ltd. This is an open access article ucontributing to cognitive dysfunction in AD. Many studies point to a
central role of a pathological level of Ab, probably in the form of
soluble dimers or oligomers, that induce synaptic impairment early
during the progression of the disease (Lacor et al., 2007; Shankar
et al., 2007; Shrestha et al., 2006). In agreement, the presence of
increased Ab is sufﬁcient to cause synaptic alterations in ex vivo
cultures and transgenic mice (Jacobsen et al., 2006; Shankar et al.,
2008; Tackenberg and Brandt, 2009).
Spines are microcompartments that display critical regulatory
roles in the integration of synaptic input and the regulation of
synaptic strength (Brandt and Paululat, 2013). According to their
shape, spines are generally categorized into three classes, mush-
room, stubby and thin (Harris et al., 1992). Mushroom-shapednder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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spines”. In contrast, thin and stubby spines represent immature,
more dynamic spines. Thin spines may be “learning spines”, and
stubby spines could represent general precursors from which thin
or mushroom spines protrude (Bourne and Harris, 2007; Petrak
et al., 2005). It is also known that changes in spine morphologies
are correlated with functional parameters and that the size of the
spine neck affects calcium compartimentalization and receptor
trafﬁcking (Grunditz et al., 2008; Kusters et al., 2013). Thus spine
neck plasticity as it occurs during the transition between mush-
room and stubby spines may have a role in changing the processing
of local synaptic signals. Loss of mushroom spines is a common
feature of several animal and cellular models of AD suggesting that
it is a relevant morphological marker for synaptic failure during
aging and disease (Tackenberg and Brandt, 2009; Zou et al., 2015)
and recently it has been demonstrated that oligomeric Ab specif-
ically reduces mushroom spines in the hippocampus (Popugaeva
et al., 2015).
Spine shape integrity and plasticity heavily depend on actin-
cytoskeleton remodeling (Alvarez and Sabatini, 2007). Addition-
ally, more recent studies indicate that microtubules (MTs) tran-
siently invade a subset of mature spines and that changes in MT
dynamics affect spine morphing and maintenance (Gu et al., 2008;
Hoogenraad and Akhmanova, 2010; Jaworski et al., 2008).
An important question is how changes of spines develop and
progress upon chronic exposure to low amounts of human Ab, a
likely scenario during the preclinical phase of AD, and how the
change in number and the morphology of the spines can be
reversed, which in turn might provide an opportunity to interfere
with spine changes and the resulting cognitive impairment. In fact,
some studies suggest that spines can recover, e.g. by washout of
acutely added Ab (Shrestha et al., 2006), or application of neutral-
izing anti-Ab antibodies (Spires-Jones et al., 2009). However,
whether other treatment options, such as those targeting MT dy-
namics, could be useful for spine recovery is unknown.
In a previous study we demonstrated that low concentrations of
human Ab lead to a decrease in spine density and a shift in spine
morphology from mature to immature spines (Tackenberg and
Brandt, 2009). Herein, we have extended the study by establish-
ing a long term ex vivo organotypic hippocampal culture to scru-
tinize the development of spine alterations over time. We further
employed this model to analyze the inﬂuence of MT-modulating
drugs at a time point when spine changes were already evident.
2. Materials and methods
Animals: Heterozygous APPSDL transgenic C57BL/6 mice
(Aventis Pharma, Vitry-sur-Seine, France) and non transgenic lit-
termates (C57BL/6 mice; Charles River Laboratories, Sulzfeld, Ger-
many and Harlan Winkelmann GmbH, Borchen, Germany) were
used. APPSDL transgenic mice express human APP695 with three
familial AD mutations under the control of the platelet-derived
growth factor b promoter (Blanchard et al., 2003). The mice ex-
press human APP at about the same level as murine endogenous
APP and produce equal amounts of soluble Ab 40 and 42 with
plaque formation in the hippocampus >18 months of age (Bakota,
unpublished observations). All animals were maintained and
sacriﬁced according to National Institutes of Health guidelines and
German animal care regulations. Genotyping was performed as
described earlier (Tackenberg and Brandt, 2009). For the experi-
ments mice of either gender were used.
Materials: Chemicals were purchased from Sigma (Deisenhofen,
Germany). Culture medium and supplements were obtained from
Sigma and Invitrogen (Carlsbad, California), culture dishes and
plates from Nunc (Roskilde, Denmark) and membrane cultureinserts from Millipore (Bedford, MA). Gamma-secretase inhibitor
N-[N-(3,5-diﬂuorophenacetyl)-1-alanyl]-S-phenylglycine t-butyl
ester (DAPT) was purchased from Merck (Darmstadt, Germany).
Epothilone D (EpoD) was prepared as previously described (Lee
et al., 2001; Rivkin et al., 2004). The spectroscopic properties of
the compound were identical to those reported in the literature.
Compound purity was >95% as determined by LC-MS and NMR
analyses.
Sindbis virus constructs: Construction of Sindbis virus
expressing EGFP-352wt tau was performed as described previously
(Shahani et al., 2006; Tackenberg and Brandt, 2009).
Organotypic hippocampal slice cultures and Sindbis virus
infection: Organotypic hippocampal slice cultures were prepared
and cultured according to (Stoppini et al., 1991). In short, one or two
week old APPSDL transgenic or non transgenic C57BL/6 mice were
decapitated, brains were removed, both hippocampi isolated and
cut into 400 mm thick slices using McIllwain tissue chopper (Gabler,
Bad Schwalbach, Germany). Slices were cultured as described
previously (Sundermann et al., 2012; Tackenberg and Brandt,
2009). On day 12 or day 17 in vitro slice cultures were infected
with Sindbis virus using droplet method (Shahani et al., 2006). For
spine analysis, cultures were ﬁxed at day 3 post infection within
six-well plates. Slices were left attached to the culture plate
membrane to preserve hippocampal structure and rinsed with PBS.
Slices were then ﬁxed with 4% paraformaldehyde in PBS containing
4% sucrose for 2 h at 4 C. After washing with PBS, cultures were
mounted with Confocal-Matrix (Micro-Tech-Lab, Graz, Austria) and
coverslipped.
Treatment of hippocampal slice cultures: To assess potential
reversibility of spine changes hippocampal slices were kept for 20
days in culture. Slices were treated with 0.5 mM DAPT, 200 nM
nocodazole, or 0.2 nM EpoD from day 16 to day 20. Sindbis virus
infection was performed on day 17.
Confocal imaging of ﬁxed hippocampal slices for spine
analysis: Confocal high-resolution imaging of spines was per-
formed using Nikon (Tokyo, Japan) confocal laser scanning micro-
scope Eclipse TE2000-U with 60 objective (oil, NA: 1.4) using
argon laser (488 nm). 20e40 mm long dendritic segments from
different hippocampal subregions (secondary and tertiary dendritic
segments of stratum oriens and stratum radiatum) of CA1 and CA3
pyramidal neurons were imaged with voxel size of
0.08  0.08  0.25 mm in xeyez direction. Image size was adjusted
according to length and shape of the imaged dendritic fragment.
Image stacks were further processed as described for morpholog-
ical spine analysis.
Image processing and semi-automated analysis of spine
density and spine morphology: Image stacks (Nikon.ids ﬁles)
were processed using 3D blind deconvolution (10e15 iterations,
Autodeblur software, Watervliet, NY) to improve signal-noise ratio
and spatial resolution. Analysis of spine length, volume and shape
was performed using 3DMA neuron software (Koh et al., 2002)
which allows algorithm-based, semi-automated evaluation of spine
morphology in 3D. Spine shape is determined by 3DMA neuron
based on the classiﬁcation of spine shapes (stubby, thin, mush-
room), given in (Harris et al., 1992). In general, the decision is based
on spine length (L), head diameter (dh) and neck diameter (dn) (see
Fig. 2A, right). For thin spines, spine length is much greater than the
neck diameter and head diameter does not exceed neck diameter
too excessively. For mushroom spines, length is not excessive, and
the head diameter is much greater than the diameter of the neck.
For stubby spines, the neck diameter is similar to the length of the
spine (the speciﬁc criteria are represented in Table 1 of Koh et al.,
2002). It is possible that due to the deconvolution the spine neck
is eliminated from the image. The 3DMA neuron software has clear
criteria how to deal with such “detached spine components” and
Fig. 1. Spine loss in vivo and in an ex vivo model of Alzheimer's disease. A. Schematic representation showing the conditions to analyze the development of spine changes at
different ages. Hippocampal slices were prepared from 7 or 14 days old mice and kept in culture for 15 or 20 days. All slices were infected 3 days before analysis with EGFP-tagged
tau for spine visualization. Time points when spine densities were determined in vivo are indicated by asterisks at the bottom. B. Representative high-resolution images of dendritic
segments of CA3 neurons (st.rad.) at the conditions shown in (A). C. Effect of culture time on spine densities in APPSDL transgenic and non transgenic cultures (CA1 and CA3 neurons;
st.rad., st.or.). Spine density is reduced in cultures from APPSDL transgenic mice compared to non transgenic controls. D. Representative images of dendritic segments of CA3 neurons
(st.rad.) from Golgi-stained brains from 3 to 5 week old APPSDL transgenic and non transgenic mice. E. Effect of age on spine densities in APPSDL transgenic and non transgenic
animals (CA1 and CA3 neurons). Spine density is reduced in brains from APPSDL transgenic mice compared to non transgenic controls. Images in (B) were processed by blind
deconvolution with Autodeblur software. Values are shown as mean ± SEM. Statistical evaluation was performed using one way ANOVAwith application of post hoc Tukey's test for
multiple comparisons (C) or post hoc Fisher's LSD test (E). See Supplementary Table 1 for details on the statistics of the culture experiments. Values in (E) are shown as mean ± SEM
(n ¼ 10e12 (CA1), n ¼ 10e11 (CA3) from at least three mice per condition). **p < 0.01, ***p < 0.001. Scale bar, 5 mm (B, D). st.or., stratum oriens; st.rad., stratum radiatum; P, days post
natal; DIV, days in vitro.
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segments and spines for visual representation (see Fig. 2A) was
performed on the 3D (deconvolved) image z-stack using the image
processing package ImageJ/Fiji (Schindelin et al., 2012). An intensity
threshold was set manually to determine the 3D structure of the
dendritic segment and the thresholded z-stack was sent for
rendering to the 3D Viewer plugin.
Brain ﬁxation and Golgi staining: APPSDL transgenic mice and
non transgenic littermates were immersion ﬁxed (3 week old pups)
or perfused transcardially (4 and 5 week old pups) with 4% para-
formaldehyde in phosphate buffer (PFA in PBS), pH 7.4. Brains were
stored in PBS at 4 C. For rapid Golgi-staining, brains were stained
according to (Hundelt et al., 2011). In short, PFA-ﬁxed brains were
incubated in 2.5% (w/v) K2Cr2O7 at 34 C for 3 days. The brains were
shortly washed in 1% (w/v) AgNO3 and incubated for 4 days at 34 C
in 1% (w/v) AgNO3. Coronal sections (200 mm) were cut in 50% (v/v)
glycerol with a vibratome and mounted on slides, embedded in
Kaiser's glycerol gelatine, and analyzedwithin twoweeks by a blind
analysis. Sections were imaged on a Nikon Eclipse TE2000-U ﬂuo-
rescence microscope equipped with a digital camera (VosskühlerCOOL-1300). Spine number per mm was determined using the
program Lucia G (Nikon).
Photoactivation and live cell imaging of PC12 cells: PC12 cells
were cultured, transfected with pSems-mPAGFP-a-tubulin, and
neuronally differentiated as described previously (Janning et al.,
2014). Cells were pretreated with EpoD or carrier alone (0.01%
DMSO) for 30 min and imaged within 1 h on a laser scanning mi-
croscope (Eclipse TE2000-U inverted; Nikon) equipped with argon
(488 nm) and blue diode (405 nm) lasers. Photoactivation in the
middle of a process and automated image acquisition was essen-
tially performed as described previously for 112 s at a frequency of 1
frame/s and a resolution of 256  256 pixels (Gauthier-Kemper
et al., 2012).
MTT assay:MTT assays were essentially performed as described
previously on 96-well plates with a cell number of 104 per well
(Fath et al., 2002). EpoD or carrier was added 3 h after plating and
MTT conversion was determined after 4 days.
Statistical analysis: Data for dendritic spine analysis are shown
as mean ± SEM. The number of mice and dendritic segments, on
which analysis for culture experiments was performed, is given in
Fig. 2. Change of spine shapes during ex vivo culture. A. Representative high resolution images of dendritic segments from CA3 st.rad. from P14DIV20 APPSDL transgenic and non
transgenic cultures after 3D rendering. The three spine categories and the designating parameters spine length (L), spine neck (dn) and head (dh) diameter are shown at the right. B.
Effect of age on spine lengths in APPSDL transgenic and non transgenic cultures (CA1 and CA3 neurons; st.rad., st.or.). Spine length is signiﬁcantly reduced at several conditions in
cultures from APPSDL transgenic mice compared to non-transgenic controls as analyzed by Tukey's multiple comparisons test. C. Effect of age on spine shape. The fraction of mature,
mushroom-shaped spines decreases whereas immature, stubby spines increase in cultures from APPSDL transgenic mice compared to non transgenic controls. The shift from
mushroom to stubby spines is most evident in the oldest cultures (P14DIV20). 3D rendering of dendritic segments and spines for visual representation in (A) was performed on the
3D (deconvolved) image z-stack using ImageJ/Fiji as described in “Materials and Methods”. (#) indicate signiﬁcant decrease compared to the respective genotype at P7DIV15. All
values are shown as mean ± SEM. Statistical evaluationwas performed using one way ANOVAwith application of post hoc Tukey's test for multiple comparisons. See Supplementary
Tables 2 and 3 for details on the statistics. st.or., stratum oriens; st.rad., stratum radiatum; P, days post natal; DIV, days in vitro; mush., mushroom-shaped spine. *(#)p < 0.05,
**p < 0.01, ***p < 0.001. Scale bar: 5 mm.
L. Penazzi et al. / Neuropharmacology 105 (2016) 84e95 87the Supplementary Tables 1e3. Statistical analysis by multiple
comparisons between more than two group means employed one-
way ANOVA with application of post hoc Tukey's test. Comparisonof spine densities of Golgi-stained brains from APP transgenic and
non transgenic animals was performed using one way ANOVAwith
application of post hoc Fisher's LSD test. For all conditions,
L. Penazzi et al. / Neuropharmacology 105 (2016) 84e9588statistical analysis was based on the number of dendritic segments
and was conducted using GraphPad Prism 6.01 software (La Jolla,
CA, USA). P values are indicated in the graphs as follows: *(þ) (#)
<0.05; **(þþ) (##)<0.01; ***(þþþ) (###)<0.001. MTT assays were
performed in triplicates.3. Results
3.1. Long term ex vivo cultures of APPSDL mice exhibit spine loss over
time in CA1 and CA3 hippocampal neurons
We previously demonstrated that cultures from APPSDL trans-
genic mice produce low equimolar amounts of human Ab1e42 and
Ab1e40 already at embryonal age (Leschik et al., 2007). Furthermore
we have shown that the presence of Ab leads to decreased spine
density on pyramidal cells of the hippocampus (Tackenberg and
Brandt, 2009). To monitor the time sequence of spine changes in
an experimentally approachable system, we established a long
term ex vivo model in which slices from APPSDL transgenic and
control micewere prepared at different days postnatal and cultured
for various periods of time to generate cultures of different age
(Fig. 1A). We analyzed spines at P7DIV15 as we found dendritic
spine pathology evident at this time point in previous studies
(Tackenberg and Brandt, 2009). To determine the effect of Ab on
spines over time we further analyzed two different later time
points by either increasing the duration in culture (P7DIV20) or by
increasing both the duration in culture and the development in vivo
(P14DIV20). Cultures, which were prepared from 7 or 14 days old
mice were vital and could be cultured for up to 20 days and suc-
cessfully infected using Sindbis virus. We refrained from using
older mice or longer culture times since the viability of the cultures
decreased and infections were less efﬁcient.
We decided to express EGFP-tagged tau for sensitive visualiza-
tion of spines by algorithm-based image analysis. The choice was
motivated by two reasons: (1) EGFP-taue compared to EGFP, which
shows due to its small size also some nuclear localization e is
completely cytosolic and more efﬁciently labels neurons with all
protrusions, (2) we have previously shown that exogenous human
tau expression does not interferewith spine density or morphology
in hippocampal slices (Shahani et al., 2006; Tackenberg and Brandt,
2009). Furthermore, we and others have shown that transgenic
expression of wild type human tau also has no effect on spine
density in the hippocampus of mice (Dickstein et al., 2010; Hundelt
et al., 2011), although the mice exhibited a shift from mushroom
spines to thin spines as a function of human tau aggregation
(Dickstein et al., 2010). Very recently it has been conﬁrmed that tau
is not required for spine loss in primary neurons (Umeda et al.,
2015).
Spine densities were evaluated in dendritic segments from
different hippocampal regions to determine potential differences
with respect to intrahippocampal connectivity. The method
employed confocal high-resolution imaging of ﬁxed slices followed
by algorithm-based image analysis with the program 3DMA
neuron. We and others had previously shown that this approach
allows sensitive and robust evaluation of dendritic spines
(Santuccione et al., 2013; Sundermann et al., 2012; Tackenberg
et al., 2013). We observed that the density of spines was reduced
in most regions and time points in APPSDL transgenic cultures
compared to control cultures (Fig. 1B, C). It should be noted that
spine density was not affected or even increased in the control
slices at the different culture conditions, indicating that our
approach permits analyzing spine changes over time at conditions
of stable spine populations.3.2. Changes in spine density ex vivo resemble the in vivo
development
Organotypic cultures preserve hippocampal circuitry and reca-
pitulate the in vivo development in many aspects (De Simoni et al.,
2003). However during longer postnatal periods or increased
in vitro culture times artefacts may occur. To determinewhether the
change in spine density in vivo reveals a pattern that reﬂects the
early Ab-related spine loss of the ex vivo cultures, brains from
APPSDL transgenic mice and control mice were ﬁxed at 3, 4 and 5
weeks of age and stained using amodiﬁed Golgi protocol. As shown
in Fig. 1A, this age period corresponds to the age of the respective
cultures (time of preparation plus days in vitro). Again, dendritic
segments of APPSDL transgenic mice had less spines in CA3 st.
radiatum compared to control animals (Fig. 1D). Quantiﬁcation
conﬁrmed that the spine density was generally lower at all time
points in CA1 and CA3 hippocampal neurons of APPSDL transgenic
compared to control mice (Fig.1E), thus resembling the ex vivo data.
3.3. Spine shapes progressively change from mushroom to stubby
with time of Ab exposure
Changes in the morphology of spines, which have been associ-
ated with functional changes of glutamatergic synapses, may
comprise early pathological changes during AD progression
(Tackenberg et al., 2009). Spines from APP transgenic cultures
showed obvious changes in their morphology compared to control
cultures in that they appeared shorter and more stubby-like
(Fig. 2A, left). To analyze the morphological changes in a more
quantitative manner, we determined the mean spine length at
different ages of the cultures. In cultures from APPSDL transgenic
mice, spine length was reduced compared to control cultures in
several conditions by using multiple comparisons test (Fig. 2B). In
most regions the difference in spine lengths markedly increased
with the age of the culture. In contrast to the differences in spine
lengths, no consistent difference was observed in spine volume,
neither with respect to the region nor with respect to the culture
time (data not shown). Thus, the data indicate that Ab induces a
progressive shortening of spines while spine volumes remain
unaffected.
To scrutinize changes in the shape of spines, the three desig-
nating parameters of spine length (L), spine neck (dn) and head (dh)
diameter were determined for the individual spines, and the spines
were then classiﬁed into the three categories, “mushroom”,
“stubby”, and “thin” by automated image analysis (Fig. 2A, right).
We found a decreased fraction of mushroom spines in Ab producing
cultures compared to controls, which was most pronounced in
older cultures (Fig. 2C). In contrast, the fraction of stubby spines
increased in Ab producing cultures. At the longest culture time
(P14DIV20) the population analysis revealed that the decrease in
the fraction of mushroom spines and the increase in stubby spines
reached signiﬁcance in all regions by multiple comparisons test
(Fig. 2C, bottom row). However, we did not observe a difference in
the fraction of thin spines.
3.4. Loss of spines and changes in spine morphology are completely
reversed after blocking Ab production with DAPT
Our long term ex vivo model provides a system to determine
whether, to what extent, and in which time scale Ab-induced spine
changes are reversible. As described before (Tackenberg and
Brandt, 2009) and above, changes in spine density and
morphology are already present at short culture times in slices
from APPSDL transgenic mice compared to control cultures
(P7DIV15; Figs. 1 and 2C) and could be blocked by the presence of
L. Penazzi et al. / Neuropharmacology 105 (2016) 84e95 89the g-secretase inhibitor DAPT (Tackenberg and Brandt, 2009).
Now, to determine how spines respond to a lowering of the amount
of Ab, we added DAPT at a time point when spine changes were
already evident (see Fig. 1C) and continued the culture for addi-
tional 4 days (P7DIV20; Fig. 3A). Automated spine detection
revealed that dendritic segments of DAPT-treated neurons became
indistinguishable from untreated control cells (Fig. 3B). Quantiﬁ-
cation conﬁrmed that DAPT completely abolished the difference in
spine densities in the CA1 and the CA3 region between cultures
from APPSDL transgenic cultures and control cultures, and that the
spine densities in DAPT-treated cultures were similar to untreatedFig. 3. Reversal of spine changes by DAPT. A. Schematic representation showing the experim
days old mice and kept in culture for 20 days. Ab-production was blocked from day 16 by
evident in cultures from APPSDL transgenic mice (P7DIV15), are indicated. B. Representative im
cultures treated with or without DAPT for 4 days. Individual spines were detected using 3DM
(D), and spine shape (E) in CA1 and CA3 neurons. Differences compared to the respective gen
and spine shape from APPSDL transgenic mice are reversed to control conditions. Values are s
compared to the respective genotype without the drug. Statistical evaluation was perform
parisons. See Supplementary Tables 1e3 for details on the statistics. P, days post natal; DIV,
p < 0.001. Scale bar: 5 mm.controls (Fig. 3C). Furthermore, DAPT also reversed the shortening
of spines, which was most evident in the CA3 region (Fig. 3D).
Classiﬁcation of spine morphologies revealed that DAPT also
reversed the shift from mushroom to stubby spines (Fig. 3E). DAPT
treatment appeared to cause also a slight increase in mushroom-
and a decrease in stubby-shaped spines in control cultures. How-
ever, these changes did not reach signiﬁcance.ental setup to analyze the recovery of spines. Hippocampal slices were prepared from 7
adding the g-secretase inhibitor DAPT. Conditions, where spine changes were already
ages of dendritic segments of CA3 neurons from non transgenic and APPSDL transgenic
A neuron software. CeE. Effect of DAPT-treatment on spine densities (C), spine lengths
otype without the drug are indicated. After DAPT treatment, spine density, spine length
hown as mean ± SEM. (þþ,þþþ) indicate signiﬁcant increase, (##) signiﬁcant decrease
ed using one way ANOVA with application of post hoc Tukey's test for multiple com-
days in vitro; mush., mushroom-shaped spine. *p < 0.05, (þþ) (##)p < 0.01, ***(þþþ)
L. Penazzi et al. / Neuropharmacology 105 (2016) 84e95903.5. Nocodazole induces spine loss of control cultures and
suppresses DAPT-induced spine recovery in APP transgenic cultures
Exposure to Ab is known to induce MT destabilization in
cultured neurons (Henriques et al., 2010; Mota et al., 2012) andMTs
may be involved in regulating spine morphology and function
(Hoogenraad and Akhmanova, 2010; Penazzi et al., 2015). To test for
an involvement of MTs we treated the cultures with the MT-
disrupting drug nocodazole at a time point when spine changes
were already evident (see Fig. 1C), and continued the culture for
additional 4 days (P7DIV20, Fig. 4A). Interestingly, we found that
while nocodazole caused spine loss in control cultures, this com-
pound did not produce the same effect in Ab-producing cultures. In
fact a small but signiﬁcant increase in spine density was observed
in nocodazole treated APP transgenic cultures (Fig. 4B). Although
the small rescuing effect caused by nocodazole in APP transgenic
cultures is somewhat surprising, this may result in part from the
fact that at low concentrations, MT-depolymerizing agents,
including nocodazole, are known to suppress MT dynamic insta-
bility (Dent and Kalil, 2001; Mikhailov and Gundersen, 1998).Fig. 4. Effect of nocodazole on spine density and DAPT-induced reversal of spines. A. Schem
alone and on DAPT-induced spine recovery. Conditions, where spine changes were already
nocodazole, DAPT, and the combination of both drugs in APPSDL transgenic and non trans
periments without drug (non transgenic and APPSDL transgenic cultures, respectively) are sho
C. Effect of nocodazole-treatment on spine shape in CA1 neurons. Representative high-resol
left. Differences compared to the respective genotype without the drug are indicated. Nocod
fraction of mushroom spines. Values are shown as mean ± SEM. (þ,þþ,þþþ) indicates sign
without the drug. Statistical evaluation was performed using one way ANOVAwith applicati
for details on the statistics. *(þ) (#)p < 0.05, **(þþ) (##)p < 0.01, ***(þþþ) (###)p < 0.001Previously it has been shown that alterations in microtubule dy-
namics are linked to spine changes (Jaworski et al., 2009). A
decrease in the distance and duration of microtubule growth re-
sults in a reduced accumulation of scaffolding proteins such as
p140Cap in dendritic protrusions, which affects the organization of
spine actin as the primary force for spine changes (Hayashi et al.,
2011; Repetto et al., 2014). Thus, conditions, which normalize MT
dynamics may positively inﬂuence actin organization in spines and,
at least partially, rescue spine loss. Nocodazole did not affect spine
morphology in control cultures as judged from the unchanged
fraction of mushroom, stubby and thin spines (Fig. 4C). However it
partially reversed the decreased fraction of mushroom spines in
APP transgenic cultures, which supports our observation regarding
the rescuing effect of nocodazole with respect to the spine density
(see Fig. 4B).
To test, whether spine recovery is MT-dependent, we triggered
the recovery of the spines by treatment with DAPT either in the
absence or in the presence of nocodazole (Fig. 4A). As expected,
DAPT treatment alone increased spine density in Ab-producing
cultures, an effect that was suppressed by the simultaneousatic representation showing the experimental setup to analyze the effect of nocodazole
evident in cultures from APPSDL transgenic mice (P7DIV15), are indicated. B. Effect of
genic cultures in CA1 neurons. Spine density changes compared to the respective ex-
wn. Nocodazole suppresses DAPT-induced spine reversal in APPSDL transgenic cultures.
ution images of dendritic segments after treatment with nocodazole are shown on the
azole changes the spine population from APPSDL transgenic mice towards an increased
iﬁcant increase, (#,##,###) signiﬁcant decrease compared to the respective genotype
on of post hoc Tukey's test for multiple comparisons. See Supplementary Tables 1 and 3
. P, days post natal; DIV, days in vitro; mush., mushroom-shaped spine. Scale bar: 5 mm.
L. Penazzi et al. / Neuropharmacology 105 (2016) 84e95 91presence of nocodazole (Fig. 4B). Taken together, the data indicate
that Ab-induced spine loss is indeed mediated by MT disruption
and that spine recovery requires MT polymerization.
3.6. Subnanomolar concentration of epothilone D reverses spine
loss in the presence of Ab
If MTs are causally involved in spine loss and growth, one might
expect that drugs, which modulate MT dynamics, support spine
recovery. The epothilones comprise a relatively large class of MT-
stabilizing agents (Altmann et al., 2009). Selected brain penetrant
examples, such as EpoD, may have neuroprotective activity and
have been proposed as potential therapeutic candidates for axo-
nopathies (Barten et al., 2012; Brunden et al., 2010; Lou et al., 2014;
Trushina et al., 2003; Zhang et al., 2012). However dose-dependent
neurotoxic effects have also been noted both with certain epothi-
lones as well as other MT-binding agents (Chiorazzi et al., 2009;
LaPointe et al., 2013).
Here we wanted to explore, whether low MT-modulating con-
centrations of EpoD could favorably affect spine parameters in the
chronic presence of Ab. We ﬁrst determined, in pilot experiments,
the effect of EpoD on cell viability using aMTTassay with PC12 cells
as a model for rodent neural cells. We observed a major decrease in
MTT conversion at a concentration of 50 nM EpoD, while concen-
trations of 1 nM or below did not cause apparent changes (Fig. 5A).
To analyze the effect of EpoD on MT stabilization, we employed a
live cell-imaging assay to determine MT dynamics in living
neuronal cells. The method is based on determination of ﬂuores-
cence decay after photoactivation (FDAP) of photoactivatable GFP-
tagged (PAGFP-tagged) a-tubulin in a region of a neuronal pro-
cess (Fig. 5B, left). FDAP thus comprises an indicator of the ratio of
soluble to polymerized tubulin. EpoD decreased FDAP in a dose
dependent manner compared with carrier-treated cells (Fig. 5B,
right). Already at a concentration as low as 0.2 nM, EpoD was suf-
ﬁcient to decrease FDAP, indicating MT-stabilizing activity.
To test whether EpoD affects Ab-induced spine loss, we treated
non transgenic and APP transgenic cultures with 0.2 nM EpoD and
analyzed spines at P7DIV15 (Fig. 5C, top). We observed that addi-
tion of EpoD to slice cultures did not affect spine density in non
transgenic cultures but led to a signiﬁcant increase in spine density
in APP transgenic cultures (Fig. 5C, left). It has previously been
observed that the presence of taxol detaches tau frommicrotubules
in living cells (Samsonov et al., 2004; Weissmann et al., 2009),
which might raise the possibility that the effect of EpoD is inﬂu-
enced by the expression of htau sequence. To test such a scenario,
we performed the same experiment also after infection with
Sindbis virus expressing EGFP alone, under which conditions we
previously observed a similar spine loss due to the presence of Ab
(Tackenberg and Brandt, 2009). We did not see a difference
compared to EGFP-tau expressing neurons conﬁrming that the
presence of exogenous htau does not affect the loss or gain of
spines, also not in the presence of EpoD (Fig. 5C, right). Again, EpoD
brought spine density of non transgenic and APP transgenic cul-
tures to the same level. To evaluate a potential effect of EpoD on
spine morphology, we determined the fraction of mushroom,
stubby and thin spines. Interestingly, EpoD changed the
morphology of the spine populations in a way that it increased the
fraction of thin spines compared to untreated cultures (Fig. 5D).
Such a change was also evident in control cultures.
To determine whether EpoD is also able to reverse Ab-induced
spine loss, we added the compound at 0.2 nM to the slice cultures at
a time point when spine changes were already evident (see Fig. 1C)
and continued the culture for additional 4 days (Fig. 5E, top). We
observed that the density of spines in APP transgenic cultures was
much higher compared to untreated controls of the same genotypeand reached a level, which was similar to non transgenic controls
(Fig. 5F). Also after spine reversal, EpoD changed themorphology of
the spine populations in most regions in a way that it increased the
fraction of thin spines and decreased the fraction of mushroom
spines (Fig. 5H). Again, the respective change was also evident in
control cultures suggesting that EpoD induces a shift of the spine
population towards more immature spine types. It is possible that
EpoD reinforces synaptogenesis by an increase in the formation of
ﬁlopodia rather than thin spines. However this is not the case, since
the majority of the thin protrusions contained a discernible head
indicative of spines (Fig. 5E), and the spine population did not
exhibit an increase in spine length (Fig. 5G), which would have
been expected after induction of ﬁlopodia, which have been re-
ported to be much longer than spines (3e40 mm compared to
0.2e2 mm; (Garcia-Lopez et al., 2010)).
4. Discussion
In this study, we established a long term ex vivomodel to follow
the development of spine changes as they might occur during a
presymptomatic stage of AD and proposed a potential therapeutic
strategy for their reversal. The major ﬁndings are: (1) ex vivo cul-
tures exhibit spine changes in CA1 and CA3 hippocampal neurons,
which closely resembles the changes occurring in vivo; (2) spines
completely recover within few days when Ab is reduced; (3) spine
recovery requires MT polymerization and a subnanomolar, non
toxic concentration of the MT-stabilizing agent EpoD reverses loss
of spines and increases thin spine density.
Loss of dendritic spines and changes in the shape and size of
spines are a common abnormality found in human AD brains
(Baloyannis et al., 2007). In contrast to the death of neurons, spine
loss occurs more widespread (Catala et al., 1988) and appears to be
an early event during the development of disease. Indeed, previous
studies found that patients in the early stages of AD have much
fewer spines in the hippocampus (Scheff et al., 2007). A signiﬁcant
reduction in the number of dendritic spines was also observed in
CA1-3 pyramidal neurons in patients with Down's syndrome (DS)
before the onset of AD (Ferrer and Gullotta, 1990). This observation
is consistent with the hypothesis that spine loss is caused by the
increase in the concentration of Ab due to the gene-doses effect in
DS. In our ex vivo model, spine loss occurred over time and
resembled the in vivo results, where it was detectable already at 3
weeks of age. Both, ex vivo and in vivo, spine loss occurred broadly
in different hippocampal subﬁelds, which also resembles the
ﬁndings in AD patients. It is however noteworthy that spine loss
was generally smaller in vivo than ex vivo, which may indicate that
organotypic hippocampal cultures are more sensitive to the pres-
ence of Ab than the hippocampus in intact brains.
Currently, most data suggest that increased levels of Ab in a
soluble, oligomeric form are the major factor that is responsible for
the spine changes (Shankar et al., 2007; Tackenberg et al., 2009).
This result is also clearly supported by our current data, as we
observed that lowering the Ab load by g-secretase inhibition not
only blocks but completely reverses spine loss and morphological
changes with spine morphology being indistinguishable from spine
populations that have never been exposed to human Ab. Further-
more, the data indicate that chronic presence of Ab causes a gradual
change in the morphology of the population of the spines from
mushroom to stubby. It should be noted that the age-related
morphological changes are in agreement with the hypothesis that
mushroom spine loss is a morphological marker for synaptic failure
during AD and aging, and stubby spines might be the morpholog-
ical correlate of the induction of long term depression (Li et al.,
2009). However, it needs to be noted that our study focuses on
spine changes observed early in development and our long term
Fig. 5. Effect of Epothilone D on cell survival, MT polymerization and spine density and morphology. A. Effect of EpoD on the survival of PC12 cells as determined byMTT conversion.
The carrier control (0.01% DMSO) is set as 100%. B. Measurement of FDAP to determine MT dynamics in neuronal processes. Neuronally differentiated PC12 cells expressing PAGFP-
tagged tubulin were focally irradiated with an UV laser in the middle of a process. FDAP, as an indicator for the ratio of soluble to polymerized tubulin, was determined in the region
of activation. The respective FDAP plots of cells treated with carrier (0.01% DMSO), and different concentrations of EpoD are shown to the right. EpoD induces a decreased FDAP
indicative for MT stabilization, which is evident already at 0.2 nM. Note that the curves for 1 and 5 nM EpoD (blue and red, respectively) run together very close. C. Schematic
representation showing the experimental setup to analyze the effect of EpoD in short term cultures (P7DIV15). Effect of EpoD treatment on spine density after expression of EGFP-
tau or EGFP alone in CA1 and CA3 neurons are shown at the bottom. EpoD abolishes the difference between Ab-producing and control cultures by increasing the spine density in
APP transgenic cultures. No difference due to the expressed construct (EGFP-tau or EGFP) is observed. D. Effect of EpoD-treatment on spine shape in CA1 and CA3 neurons after
expression of EGFP-tau. Differences compared to the respective genotype without the drug are indicated. EpoD changes the spine population from APPSDL transgenic and non
transgenic mice towards an increased fraction of thin spines. E. Schematic representation showing the experimental set-up to analyze the effect of EpoD on spine recovery.
Conditions, where spine changes were already evident in cultures from APPSDL transgenic mice (P7DIV15), are indicated. Representative high-resolution images of dendritic
segments after treatment with EpoD are shown at the bottom. FeH. Effect of EpoD-treatment on spine densities (F), spine lengths (G), and spine shape (H) in CA1 and CA3 neurons.
Differences compared to the respective genotype without the drug are indicated. EpoD abolishes the difference between Ab-producing and control cultures with respect to all
parameters. Note that EpoD induces an increase in the fraction of thin spines, which is evident at most conditions. In (A), mean and range from two independent experiments with
three technical replicates each are shown. FDAP curves in B are based on n ¼ 11e24 measurements per experimental condition. In (CeH), values are shown as mean ± SEM.
(þ,þþ,þþþ) indicate signiﬁcant increase, (#,##,###) signiﬁcant decrease compared to the respective genotype without the drug. Statistical evaluation was performed using one
way ANOVA with application of post hoc Tukey's test for multiple comparisons. See Supplementary Tables 1e3 for details on the statistics. *(þ) (#)p < 0.05, (þþ) (##)p < 0.01,
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in older animals in which AD pathology is more established and
joined by other pathological hallmarks. Since the preparation of
vital organotypic cultures is restricted to young postnatal stages,
other approaches would be required. These could involve the use of
acute hippocampal slices from animals expressing ﬂuorescent
markers in individual neurons, such as the GFP M line (Feng et al.,
2000). It will be interesting to determine, whether changes in the
population of spines can also be reversed in older animals and
whether MT dependent mechanisms are involved.
It has previously been shown that exposure of neuronal cultures
to Ab induces MT destabilization as evidenced by a decreased ratio
of acetylated tubulin and reduced MT polymer (Henriques et al.,
2010; Mota et al., 2012), however also potential microtubule sta-
bilizing effects have been reported (Pianu et al., 2014) as judged
from an increased formation of detyrosinated microtubules. Very
recently, Tsushima et al. (Tsushima et al., 2015) provided evidence
that Ab increases MT instability by inhibiting HDAC6, which might
provide a direct link between Ab and the regulation of neuronal
microtubule dynamics. This could suggest that the activity of Ab to
induce spine loss is related to its MT destabilizing effect. This is in
agreement with our observation that the MT-destabilizing drug
nocodazole leads to a loss of spines in control cultures closely
resembling the effect of Ab. It should however be noted that our
experiments do not allow to distinguish between a general effect of
Ab on destabilizing pre-existing microtubule networks or inter-
fering with dynamic microtubules that may target spines. The ef-
fect of Ab to induce spine loss in organotypic cultures requires
NMDA receptor activation and is independent from the action of
tau (Tackenberg and Brandt, 2009; Tackenberg et al., 2013). This
differs from reports, where dissociated cultures have been
employed and tau-dependent spine loss was observed (Zempel
et al., 2013).
Finally, we have demonstrated that a subnanomolar concen-
tration of EpoD at conditions, which slightly stabilize MTs but do
not exhibit apparent toxicity, have the potential to completely
reverse spine loss even in the continuous presence of Ab. It should
be noted that also low concentrations of nocodazole had a beneﬁ-
cial effect on spine density in slices from APP transgenic mice,
whereas nocodazole induced spine loss in non transgenic cultures.
Since low concentrations of MT-depolymerizing agents are known
to suppress MT dynamic instability (Dent and Kalil, 2001;
Mikhailov and Gundersen, 1998), this might point to the fact that
physiological spine regulation is dependent on a delicate balance of
MT dynamics, where deviations in both directions (increased
destabilization on one side or increased stabilization on the other)
are of negative impact. We observed that EpoD mediated spine
recovery in parallel to the induction of a shift of the spine popu-
lation towards more immature spine types. Also in control cultures,
EpoD led to a similar shift in the population frommushroom to thin
spines indicating that even moderate changes in MT dynamics in-
ﬂuence spine morphology. This is consistent with previous studies
where it has been shown that activity-dependent invasion of MTs
in spines alters spine morphology (Hu et al., 2008). The data indi-
cate thatMTstabilization by a subnanomolar concentration of EpoD
promotes a change in the population of spine types towards more
immature spines, which might facilitate spine recovery in a short
time interval. It remains to be shown whether the EpoD-induced
increase in spine density is beneﬁcial despite the simultaneous
shift of spine morphology. This will require functional analysis, e.g.
by electrophysiological recordings of slice cultures in the presence(þþþ) (###)p < 0.001. st.or., stratum oriens; st.rad., stratum radiatum; P, days post natal; DIV
the references to colour in this ﬁgure legend, the reader is referred to the web version of tor absence of EpoD. It should however be noted that behavioral
studies provided evidence that treatment with a MT stabilizing
drug (paclitaxel) restored memory formation in nocodazole-
treated mice (Fanara et al., 2010).
In contrast to paclitaxel and most other taxanes, EpoD and
selected congeners are brain penetrant, which is an essential
requirement in the development of any CNS active therapeutic
candidate for the treatment of AD and related neurodegenerative
diseases (Ballatore et al., 2012). Previously it has been reported that
EpoD reduces transport deﬁcits and improves cognition in different
tau transgenic mice by stabilizing axonal MTs (Barten et al., 2012;
Brunden et al., 2010; Zhang et al., 2012), however also a negative
impact on dendritic arborisation has been observed (Golovyashkina
et al., 2015). Recent data show that EpoB or D promote axon
regeneration after transection injury in vitro and spinal cord injury
(Brizuela et al., 2015; Ruschel et al., 2015). Our data clearly indicate
that EpoD, even at very low concentrations, can produce a promi-
nent dendritic effect and rescue spine loss, suggesting that mild
modulation of MT dynamics may be an effective strategy to coun-
teract synaptic impairment already in the preclinical state of AD.
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